Home › Pituitary Tumors › NCT00599092
Pituitary Tumor Surveillance: Pathogenic Correlation
RecruitingObservational studyHealthy volunteers welcome
Pituitary Tumor Surveillance: Pathogenetic Correlation
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * patients with confirmed pituitary disease Exclusion Criteria: * patients who do not have confirmed pituitary disease
About the study
The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity in patients harboring pituitary mass lesions of all types.
Sponsor: Cedars-Sinai Medical Center · Participants: 1,250 · Started: 1997-01
Contact the study team
Official record on ClinicalTrials.gov — NCT00599092
Locations in the U.S.
| California | Cedars-Sinai Medical Center, Pituitary Center, Los Angeles |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.